In today’s swine industry, unpredictability is the biggest challenge. Health risks, labor shortages, and inconsistent results can undermine even the most well-managed farms. The Nexus 100 was developed to address these pressures directly, offering producers a solution that performs consistently, survives better, and integrates seamlessly into high-pressure operations to help them grow ahead with confidence.
“Nexus is not just a new product line. It’s a smart step forward for producers who demand more than just output,” said Raf Beeren, Managing Director of Hendrix Genetics Swine. “It’s designed for those who aim for Total System Profitability through consistency, efficiency, and control.”
The Nexus 100 is produced combining the genetics of Hypor and Danish Genetics. This unique cross delivers a balanced profile between the robustness of the Danish Hybrid and the mothering abilities of the Hypor Libra, resulting in 15 weaned piglets per litter. The focus is not on maximizing litter size, but on maximizing survivability, ensuring every piglet counts.
“The Nexus 100 is produced within a 100% PRRS-free breeding program, backed by Denmark’s world-class health standards and decades of controlled breeding excellence,” added Manuel Revilla, Global Customer Services Manager at Hendrix Genetics Swine.
Already in production for several months, the Nexus 100 has demonstrated the highest survivability rate in its category, helping producers reduce losses, save labor, and improve overall performance. It benefits from Hendrix Genetics’ multi-species expertise and state-of-the-art R&D, combining proven health with continuous genetic progress.
Commercial contracts for the Nexus 100 can already be initiated, with delivery starting in spring 2026. Hendrix Genetics Swine also confirms that more products under the Nexus brand are in development, committing to drive progress and deliver value across the global pork value chain.